Alban Dufumier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alban dufumier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alban Dufumier Today - Breaking & Trending Today

TP ICAP Midcap Initiates Coverage of Oncodesign Precision Medicine With a "Buy" Recommendation

TP ICAP Midcap Initiates Coverage of Oncodesign Precision Medicine With a "Buy" Recommendation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France General , United States , Karine Lignel , Arthur Rouill , Mathilde Bohin Alban Dufumier , Precision Medicine , Effective Therapeutic , Oncodesign Precision Medicine , Alban Dufumier , Oncodesign Precision ,

OPM Announces Positive Interim Results of Its Phase 1 Study Evaluating OPM-101 in Healthy Volunteers

OPM Announces Positive Interim Results of Its Phase 1 Study Evaluating OPM-101 in Healthy Volunteers
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France General , Jan Hoflack , Arthur Rouill , Mathilde Bohin Alban Dufumier , Karine Lignel , Data Review Committee , Precision Medicine , Chief Scientific Officer , Chief Executive Officer , Oncodesign Precision Medicine , Alban Dufumier , Oncodesign Precision ,

OPM Announces Positive Interim Results of Its Phase 1 Study Evaluating OPM-101 in Healthy Volunteers

Completion of the single-dose administration (SDA) part of the Phase 1 healthy volunteers study of OPM-101 and transition to the multiple-dose escalation administration (MDA)A new mechanism of action normalizing TNF-alpha secretion and targeting chronic inflammatory bowel disease (IBD)Excellent tolerability with no. ....

France General , Mathilde Bohin Alban Dufumier , Jan Hoflack , Arthur Rouill , Karine Lignel , Data Review Committee , Regulatory News , Precision Medicine , Chief Scientific Officer , Chief Executive Officer , Oncodesign Precision Medicine , Alban Dufumier ,

OPM Announces Its 2022 Annual Results and Provides an Update on Its Clinical Developments

Revenues and operating income in 2022 of €8.3 M (+110% vs. 2021 proforma), including revenues of €8 M, mainly driven by a €7 M milestone and a €0.5 M up-frontNet income almost at break-even (€0.2) MStrong financial visibility with a cash position of €13.4 M ensuring the development of our programs for the coming yea. ....

Philippe Genne , Arthur Rouill , Karine Lignel , Jan Hoflack , Mathilde Bohin Alban Dufumier , Research Tax Credit , Transition Service Agreement , Oncodesign Services , Regulatory News , Precision Medicine , Chief Executive Officer , Oncodesign Biotechnology , Euronext Growth , Artificial Intelligence , Monday April , Ordinary General Meeting , Oncodesign Precision Medicine , Alban Dufumier ,